Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.18 (
glutathione S-transferase
)
22,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Association of the condensin multiprotein complex with chromatin is required for chromosome condensation at mitosis. What regulates condensin targeting to chromatin is largely unknown. We previously showed that the nuclear A kinase-anchoring protein,
AKAP95
, is implicated in chromosome condensation. We demonstrate here that
AKAP95
acts as a targeting protein for human chromosome-associated protein (hCAP)-D2/Eg7, a component of the human condensin complex, to chromosomes. In HeLa cell mitotic extract,
AKAP95
redistributes from the nuclear matrix to chromatin. When association of
AKAP95
with chromatin is prevented, the chromatin does not condense. Condensation is rescued by a recombinant
AKAP95
peptide containing the 306 COOH-terminal amino acids of
AKAP95
. Recombinant
AKAP95
binds chromatin and elicits recruitment of Eg7 to chromosomes in a concentration-dependent manner. Amount of Eg7 recruited correlates with extent of chromosome condensation: resolution into distinct chromosomes is obtained only when near-endogenous levels of Eg7 are recruited. Eg7 and
AKAP95
immunofluorescently colocalize to the central region of methanol-fixed metaphase chromosomes.
GST
pull-down data also suggest that
AKAP95
recruits several condensin subunits. The results implicate
AKAP95
as a receptor that assists condensin targeting to chromosomes.
...
PMID:A kinase-anchoring protein (AKAP)95 recruits human chromosome-associated protein (hCAP)-D2/Eg7 for chromosome condensation in mitotic extract. 1079 67
Protein kinase A (PKA)-anchoring protein
AKAP95
is localized to the nucleus in interphase, where it primarily associates with the nuclear matrix. A yeast two-hybrid screen for
AKAP95
interaction partners identified the minichromosome maintenance (MCM) 2 protein, a component of the pre-replication complex.
AKAP95
-MCM2 interaction was mapped to residues 1-195 of
AKAP95
and corroborated by
glutathione S-transferase
precipitation and immunoprecipitation from chromatin. Disruption of
AKAP95
-MCM2 interaction with an
AKAP95
-(1-195) peptide within HeLa cell nuclei abolishes initiation of DNA replication in G1 phase and the elongation phase of replication in vitro without affecting global nuclear organization or import. Disruption of the C-terminal zinc finger of
AKAP95
reduces efficiency of replication initiation. Disruption of the PKA-binding domain does not impair replication in G1- or S-phase nuclei, whereas a PKA inhibitor affects the initiation but not the elongation phase of replication. Depleting
AKAP95
from nuclei partially depletes MCM2 and abolishes replication. Recombinant
AKAP95
restores intranuclear MCM2 and replication in a dose-dependent manner. Our results suggest a role of
AKAP95
in DNA replication by providing a scaffold for MCM2.
...
PMID:Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication. 1274 Mar 81